Alzheimer's Research UK Conference
It was fantastic to see so many clinicians engaging with each other and discussing a range of key topics across the clinical landscape during the Alzheimer’s Research UK Clinical Conference 2021. We made the decision to hold the event virtually because of the COVID-19 pandemic. But despite not being together in person, with more than…
The onset of spring means not only lighter and longer days but also the annual Alzheimer’s Research UK Research Conference.
Although we couldn’t meet in person this year, our team worked hard to recreate the event virtually and bring together dementia researchers from all around the world.
The 2021 Early Career Researcher Day demonstrates Alzheimer’s Research UK is at the forefront of dementia research allowing scientists to connect and learn from each other.
We hatched a plan to make sure that this year’s conference went ahead, but safely in light of the current coronavirus outbreak. It led to a huge social media effort to recreate the conference virtually on Twitter.
Dr Jason Sang revealed fascinating insights on how we can learn from the science behind diseases like Creutzfeldt Jakob Disease (CJD) in humans, or BSE in cattle (also known as mad cow disease), to make progress in tackling the diseases that cause dementia.
Earlier this month, the Alzheimer’s Research UK Annual Research Conference took place in Harrogate. More than 500 delegates came together to share ideas and new findings. But what did we learn from the presentations and discussions?
A highlight of the conference, in which so much was covered, was a presentation from Dr John Skidmore, Chief Scientific Officer at our Cambridge Drug Discovery Institute (DDI).
It was inspiring to see so much pioneering dementia research underway in the UK and to hear about the ambitious initiatives that are taking on our greatest medical challenge.
Dr Davina Hensman Moss is a Neurology Registrar and Clinical Fellow. She has just been announced as the winner of the Jean Corsan Prize for the best scientific paper published by a PhD student at Alzheimer’s Research UK’s 2018 Research Conference in London.
I’m currently studying for a PhD at the University of Manchester, taking a closer look at a protein called tau – a key hallmark of Alzheimer’s disease and other types of dementia.